We investigated whether plasma -3 fatty acid concentrations ( eicosapentaenoic acid and docosahexaenoic acid ) modify the treatment effect of homocysteine-lowering B vitamins on brain atrophy rates in a placebo-controlled trial ( VITACOG ) .